Pfizer (PFE) Q1 2024 Earnings Call Transcript

PFE earnings call for the period ending March 31, 2024.

Related Keywords

Japan ,Italy ,Australia ,Norway ,United States ,Saudi Arabia ,France ,China ,Germany ,American ,Kingdom Of Saudi Arabia ,Carter Gould ,Carter Gould Barclays ,Mohit Bansal ,Louise Chen Cantor Fitzgerald ,Dave Risinger ,Rajesh Kumar ,Terence Flynn Morgan Stanley ,Mikael Dolsten ,Rd Doug Lankler ,Geoff Meacham ,Aamir Malik ,Trung Huynh ,Francesca Demartino ,Terence Flynn ,Srikripa Devarakonda ,Evan Seigerman ,Louise Chen ,Christ Schott Jpmorgan ,Dave Risinger Leerink ,America Merrill Lynch ,Akash Tewari Jefferies ,Albert Bourla ,Srikripa Devarakonda Truist ,Steve Scala ,Doug Lankler ,Chris Shibutani Goldman Sachs ,Chris Shibutani ,Chris Boshoff ,Chris Schott ,Akash Tewari ,Tim Anderson ,Dave Denton ,Tim Anderson Wolfe Research Analyst ,Goldman Sachs ,Pfizer ,Wolfe Research ,Vaccine Technical Committee ,Company Analyst ,Wells Fargo ,Geoff Meacham Bank ,American Society Of Clinical Oncology ,Morgan Stanley ,Pfizer International ,Barclays ,Investor Relations ,Alexandre De Germay ,Chief Executive ,Oncology Innovation Day ,Inflation Reduction Act ,American Society ,Clinical Oncology ,Pfizer International Commercial ,Vice President ,Chief International Commercial ,Chief Oncology ,New England Journal ,Vamil Divan ,Maybe Alexandre ,Scientific Officer ,Umer Raffat ,Lilly Direct ,Fargo Securities ,Breakthrough Designation ,Chief Business ,Executive Vice President ,Guggenheim Partners ,Leerink Partners ,Chief Scientific Officer ,Truist Securities ,